BTK drugs for Mantle Cell Lymphoma
4 tracked BTK drugs in the Mantle Cell Lymphoma race. The class explanation lives on the BTK page; the full indication pipeline across every mechanism is on the Mantle Cell Lymphoma page.
3 approved / phase 41 Phase 3
Head-to-head evidence: Acalabrutinib vs Ibrutinib · Acalabrutinib vs Pirtobrutinib · Acalabrutinib vs zanubrutinib · Ibrutinib vs zanubrutinib · Pirtobrutinib vs zanubrutinib